Europe radiotherapy market is projected to register a CAGR of 5.1% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
Europe Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/Radiopharmaceuticals & Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software & Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer & Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics & Others), Distribution Channel (Direct Tender, Retail Sales & Others), Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey Ukraine & Rest of Europe) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Europe radiotherapy market are:

• Increasing technology advancement in radiotherapy products
• Increasing cancer treatment procedure

Market Players:

The key market players for Europe radiotherapy market are listed below:

• Varian Medical Systems, Inc.
• Mevion Medical Systems
• VIEWRAY TECHNOLOGIES, INC. (a subsidiary of VIEWRAY)
• Siemens Healthcare GmbH
• Elekta AB, Accuray Incorporated
• IBA Worldwide
• Eckert & Ziegler BEBIG
• RaySearch Laboratories
• Brainlab AG
• Koninklijke Philips N.V.
• GE Healthcare, Hitachi, Ltd.
• Advanced Accelerator Applications (A Subsidiary of Novartis AG)
• Nordion (Canada) Inc.
• Sumitomo Heavy Industries, Ltd.